What is NDC 72205-222?

72205-222 is the product NDC for Perampanel, Perampanel 4 mg/1 tablet, film coated, listed with the FDA by Novadoz Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Perampanel?

25 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Perampanel NDC 72205-222 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-222Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0222Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72205-222-30	7220502223072205022230	30 TABLET, FILM COATED in 1 BOTTLE (72205-222-30)Marketed from Nov 26, 2025
72205-222-90	7220502229072205022290	90 TABLET, FILM COATED in 1 BOTTLE (72205-222-90)Marketed from Nov 26, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Perampanel
Generic name (nonproprietary): perampanel
Active ingredients: Perampanel — 4 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Novadoz Pharmaceuticals LLCNDC labeler code 72205
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218178
Marketing start: Nov 25, 2025
Listing expires: Dec 31, 2026
DEA schedule: CIII
Other FDA classes: AMPA Receptor Antagonists (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)UGT1A9 Inhibitors (Mechanism)UGT2B7 Inhibitors (Mechanism)
Identifiers: Product ID 72205-222_695c8c73-39cb-4927-bdf6-72d16e4aa9bbSPL ID 695c8c73-39cb-4927-bdf6-72d16e4aa9bbSPL set ID 695c8c73-39cb-4927-bdf6-72d16e4aa9bbRxCUI 1356557, 1356570, 1356574, 1356578, 1356582, 1356586UNII H821664NPKUPC 0372205221901, 0372205225909, 0372205226302, 0372205222908, 0372205225305, 0372205223905, 0372205223301, 0372205221307, 0372205224308, 0372205224902, 0372205226906, 0372205222304
Pharmacologic class: Noncompetitive AMPA Glutamate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472205022230 followed by a unit qualifier and the quantity

Package 72205-0222-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 26, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Perampanel, a non-competitive AMPA glutamate receptor antagonist, is indicated for: Treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older ( 1.1 ) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older ( 1.2 ) 1.1 Partial-Onset Seizures Perampanel tablets are indicated for the treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures Perampanel tablets are indicated as adjunctive therapy for the treatment of prim…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72205-222

What is NDC 72205-222?: 72205-222 is the product NDC for Perampanel, Perampanel 4 mg/1 tablet, film coated, listed with the FDA by Novadoz Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Perampanel.
What is the active ingredient?: Perampanel.
Who is the labeler?: Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Perampanel?: 25 other product NDCs are listed under this name. See all Perampanel NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Perampanel NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Perampanel	Perampanel 2 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-084	84386-0084-0384386-0084-30
Perampanel	Perampanel 4 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-085	84386-0085-0384386-0085-30
Perampanel	Perampanel 6 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-086	84386-0086-0384386-0086-30
Perampanel	Perampanel 8 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-087	84386-0087-0384386-0087-30
Perampanel	Perampanel 10 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-088	84386-0088-0384386-0088-30
Perampanel	Perampanel 12 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-089	84386-0089-0384386-0089-30
Perampanel	Perampanel .5 mg/mL	SuspensionOral	Sun Pharmaceutical Industries, Inc.	51672-4256	51672-4256-09
Perampanel	Perampanel 2 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	51672-4204	51672-4204-0351672-4204-06
Perampanel	Perampanel 4 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	51672-4205	51672-4205-0251672-4205-06
Perampanel	Perampanel 6 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	51672-4206	51672-4206-0251672-4206-06

All 26 Perampanel NDCs

Other NDCs under ANDA 218178

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218178
Product	Strength	Form · route	Labeler	Product NDC
Perampanel	Perampanel 2 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-221
Perampanel	Perampanel 6 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-223
Perampanel	Perampanel 8 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-224
Perampanel	Perampanel 10 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-225
Perampanel	Perampanel 12 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-226